The immunological profile of a new immunomodulatory agent, oxamisole
- 1 January 1988
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 10 (5) , 609-618
- https://doi.org/10.1016/0192-0561(88)90080-x
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Inhibition of murine hepatitis virus infections by the immunomodulator 2,3,5,6,7,8-hexahydro-2-phenyl-8,8-dimethoxy-imidazo[1,2a]pyridine (PR-879-317A)Antimicrobial Agents and Chemotherapy, 1987
- PR 879-317A enhances in vitro immune activity of peripheral blood mononuclear cells from patients with down syndromeInternational Journal of Immunopharmacology, 1987
- Association of decreased T-cell-mediated natural cytotoxicity and interferon production in Down's SyndromeClinical Immunology and Immunopathology, 1984
- An assessment of the delayed hypersensitivity reaction to methylated bovine serum albumin in the mouse and its use in the evaluation of drug effects on cell mediated immune reactionsInflammation Research, 1979
- Effects of levamisole on human monocyte function and immunoprotein receptorsClinical Immunology and Immunopathology, 1976
- LEVAMISOLE AND FUNCTIONS OF PERITONEAL MACROPHAGESThe Lancet, 1975